Evidence map›Paper›PMID 30646635›Full record

ArticlePharmaceuticals (Basel, Switzerland)2019

Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar Activities.

Chrysoula Vraka, Verena Pichler, Neydher Berroterán-Infante, Tim Wollenweber, Anna Pillinger, Maximilian Hohensinner, Lukas Fetty, Dietrich Beitzke, Xiang Li, Cecile Philippe and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Chrysoula VrakaDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. chrysoula.vraka@meduniwien.ac.at.ORCID 0000-0003-2065-6093
Verena PichlerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. verena.pichler@meduniwien.ac.at.ORCID 0000-0003-4544-2438
Neydher Berroterán-InfanteDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. neydher.berroteraninfante@meduniwien.ac.at.ORCID 0000-0002-9247-6457
Tim WollenweberDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. tim.wollenweber@meduniwien.ac.at.
Anna PillingerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. anna.pillinger@meduniwien.ac.at.
Maximilian HohensinnerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. maximilian.hohensinner@meduniwien.ac.at.
Lukas FettyDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. lukas.fetty@meduniwien.ac.at.
Dietrich BeitzkeDepartment of Biomedical Imaging and Image-guided Therapy, Division of Cardiovascular and Interventional Radiology, Medical University of Vienna, 1090 Vienna, Austria. dietrich.beitzke@meduniwien.ac.at.
Xiang LiDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. xiang.li@meduniwien.ac.at.
Cecile PhilippeDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. cecile.philippe@meduniwien.ac.at.
Katharina PallitschInstitute of Organic Chemistry, University of Vienna, Vienna 1090, Austria. katharina.pallitsch@univie.ac.at.
Markus MitterhauserDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. markus.mitterhauser@meduniwien.ac.at.ORCID 0000-0003-3173-5272
Marcus HackerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. marcus.hacker@meduniwien.ac.at.
Wolfgang WadsakDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090Vienna, Austria. wolfgang.wadsak@meduniwien.ac.at.ORCID 0000-0003-4479-8053
Medical University of Vienna · ATCenter For Biomarker Research In Medicine · ATLudwig Boltzmann Institute Applied Diagnostics · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tracer

Indexed as

apparent molar activityKeywords: [11C]meta-hydroxyephedrineradiosynthesisseparation

Identifiers

PMID30646635
PMCPMC6469290
OpenAlexW2908947143

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.